Metsera, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Metsera, Inc. and other ETFs, options, and stocks.About MTSR
Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
CEOChristopher Whitten Bernard
CEOChristopher Whitten Bernard
Employees81
Employees81
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2022
Founded2022
Employees81
Employees81
MTSR Key Statistics
Market cap3.11B
Market cap3.11B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume840.43K
Average volume840.43K
High today$29.66
High today$29.66
Low today$25.63
Low today$25.63
Open price$25.66
Open price$25.66
Volume1.05M
Volume1.05M
52 Week high$32.81
52 Week high$32.81
52 Week low$12.30
52 Week low$12.30
People also own
Based on the portfolios of people who own MTSR. This list is generated using Robinhood data, and it’s not a recommendation.